Cartesian Therapeutics
RNAC
#6916
Rank
S$0.58 B
Marketcap
$23.00
Share price
2.68%
Change (1 day)
-50.60%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -S$0.33 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are S$54.1 Million. In 2023 the company made an earning of -S$0.32 Billion a decrease over its 2022 earnings that were of S$50.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.33 Billion3.24%
2023 -S$0.32 Billion-724%
2022 S$50.94 M-649.67%
2021 -S$9.27 Million-89.78%
2020 -S$90.73 Million25.06%
2019 -S$72.55 Million-15.68%
2018 -S$86.04 Million-0.43%
2017 -S$86.41 Million83.41%
2016 -S$47.11 Million44.3%
2015 -S$32.65 Million